In the News

1858 News Items found
Physician-scientist Luc Morris
In the Lab
MSK researchers shed light on how the number of mutations in a tumor affect a patient’s response to immunotherapy drugs.
Carol Brown, MD
Gynecologic cancer surgeon Carol Brown featured in Crain's New York Business’ Notable Black Leaders and Executives list.
Dr. Robert Motzer speaks to a patient
MSK's Robert Motzer presented positive data from a phase III randomized study that assessed two different treatment combinations as first-line therapies that may benefit people with advanced kidney cancer.
Genetic counselor Elise Fiala and pediatric cancer expert Michael Walsh
Finding
The largest study of its kind to look at data from children with cancer finds inherited cancer genes are more common than expected.
Roberta Zappasodi, Taha Merghoub, and Jedd Wolchok. Photo credit: Flynn Larsen for Ludwig Cancer Research
More sugar available for immune cells could mean better immune responses against cancer.
Al Roker
TV anchor Al Roker discusses his own prostate cancer experiences, disparities in cancer care and outcomes for people of color, the importance of cancer screening for Black men, and more with Dr. Carol Brown, a gynecological oncology surgeon at Memorial Sloan Kettering and Nicholls-Biondi Chair for Health Equity at Memorial Sloan Kettering.
Dr. Santosha Vardhana
During the AACR COVID-19 and Cancer Meeting, several MSK physicians presented information about providing safe patient care, vaccines, and clinical research.
Tracy-Ann Moo
Hear from Memorial Sloan Kettering breast surgical oncologist Tracy-Ann Moo about her experience as a woman of color in medicine.
Scientists Jan Remsik, Adrienne Boire, and Jessica Wilcox in the lab
Finding
The presence of inflammatory molecules in the cerebrospinal fluid appears to be causing many of the neurologic effects seen in people with COVID-19.
Hans-Guido Wendel
Originally explored as a cancer drug, the tree-derived chemical is now being mined for its antiviral properties.